With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

Thiruvananthapuram: Rajiv Gandhi Centre for Biotechnology (RGCB) was selected as one of the four next-generation sequencing (NGS) hubs for Metagenomic.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion ...

Comparing proteomics to genomics reveals essential insights into their contributions to systems biology and experimental ...

DELRAY BEACH, Fla., Nov. 25, 2025 /PRNewswire/ -- The global Veterinary Reference Laboratory Market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at ...

Arima Genomics, Inc ., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced new data to be presented at the ...

Studies Demonstrate xCellSense® Platform's Ability to Predict Clinical Response and Enable Patient Stratification for Drug Development.